Written by Caroline Craven, Health Line, Jun 24, 2016.
Treatments involving stem cells have shown promising results in the battle against multiple sclerosis, but FDA approval still awaits.
There’s a lot of hype about stem cell therapy and how it can stop multiple sclerosis (MS) in its tracks.
But it’s taking a long time for stem cell therapy to make waves in the United States despite some success in other parts of the world.
The U.S. National Library of Medicine and the National Institutes of Health (NIH) are touting stem cell therapy. But it has yet to be approved by the Food and Drug Administration (FDA).
Two Americans stand out in the race to use stem cell therapy to treat people who have MS.
One is Dr. Richard Burt, chief of the division of medicine-immunotherapy and autoimmune diseases at Northwestern University. He’s been a stem cell therapy advocate for more than 30 years.
The other is Dr. Saud Sadiq, director and chief research scientist at the Tisch MS Research Center of New York. (Sadiq took a very creative route raising more than $300,000 with an Indiegogo account for initial funding of his research.)

Read More…

Write a comment:


Your email address will not be published.